
    
      The individual clinical investigation period will be 12 weeks per patient. If the patient
      will take part in the follow up, the individual clinical investigation period will be 64
      weeks.

      Patients receive one weekly Adacolumn® apheresis over 5 consecutive weeks. The treating
      investigator may decide to add up to 3 treatments based on his judgment.

      Treatment details Day -07: Screening; Day 00 Baseline: 1st Adacolumn® apheresis; Day 07: 2nd
      Adacolumn® apheresis; Day 14: 3rd Adacolumn® apheresis; Day 21: 4th Adacolumn® apheresis; Day
      28: 5th Adacolumn® apheresis; Week 12:Final evaluation
    
  